In the following, we are pleased to provide an overview of projects with EURAMED involvement.
The ‘CONCERT-European Joint Programme for the Integration of Radiation Protection Research’ under Horizon 2020 aims to contribute to the sustainable integration of European and national research programmes in radiation protection. CONCERT as a co-fund action strives to achieve the attraction and pooling of national research efforts in Radiation Protection with EURATOM research programmes in order to make better use of public R&D resources and to tackle common European challenges in radiation protection more effectively by joint research efforts in key areas. In order to rise to this challenge CONCERT is operating as an umbrella structure for the research initiatives of the radiation protection research platforms MELODI, ALLIANCE, NERIS, EURADOS and EURAMED.
EURAMED became a beneficiary of the project after its establishment as a legal entity, in early 2018 and is represented on the management board and contributes to the medical aspects of the project.
For more info, please visit http://www.concert-h2020.eu/
The MEDIRAD project studies the “Implications of Medical Low Dose Radiation Exposure” and has received funding from the European Commission under the Horizon 2020 programme. It aims to enhance the scientific bases and clinical practice of radiation protection in the medical field and thereby addresses the need to better understand and evaluate the health effects of low-dose ionising radiation exposure from diagnostic and therapeutic imaging and from off-target effects in radiotherapy. The project received 10 million Euros in funding from the European Commission and started in June 2017. MEDIRAD brings together over 70 scientists from 34 organisations and 14 countries and will significantly improve our scientific understanding and practice of radiation protection in the medical field. MEDIRAD is coordinated by EIBIR with Prof. Elisabeth Cardis as Scientific Coordinator (ES) and Prof. Guy Frija as Clinical Coordinator (FR).
In the preparation phase EURAMED and its individual medical associations provided strategic guidance and input to the development of the project.
EURAMED is a member of the project Stakeholder Board and invited to the annual consortia meetings to comment on the research work and project progress from a stakeholder perspective and will also be involved in the development of the science-based policy recommendations.
For more info, please visit http://www.medirad-project.eu/
The 3-year EURAMED rocc-n-roll project aims to propose an integrated and coordinated European approach to research and innovation in medical applications of ionising radiation and related radiation protection based on stakeholder consensus and existing activities in the field (incl. existing SRAs of radiation protection platforms, EC health and digitisation programmes, EURATOM-funded projects, SAMIRA initiative). To achieve this, research and radiation protection needs in the clinical disciplines using ionising radiation will be analysed with the aim to generate the largest benefit for the European population in an equal, safe, high-quality way throughout Europe by fostering clinical translation, while also strengthening economic growth and industrial competitiveness, supported by research and innovation in the field.
The project kicked off in September 2020. It involves 29 project partners from 17 countries and is coordinated by EIBIR with Prof. Christoph Hoeschen (DE) acting as Scientific Coordinator and Prof. Guy Frija (FR) as Clinical Coordinator.
EURAMED chairs the project Advisory Board and is involved in various project panels. Moreover, EURAMED members are directly involved as project beneficiaries.
For more info, please visit https://roccnroll.euramed.eu/
The 4-year SINFONIA project will develop novel methodologies and tools that will provide a comprehensive a risk appraisal for detrimental effects of radiation exposure on patients, workers, carers and comforters, the public and the environment during the management of patients suspected or diagnosed with lymphoma and brain tumours.
The project started in September 2020. The multidisciplinary project consortium combines the expertise of 14 partners from 8 countries. It includes major universities, research institutes, hospitals and industry partners.
SINFONIA is coordinated by EIBIR with Prof. John Damilakis (GR) acting as Scientific Coordinator. Many EURAMED representatives are directly involved in the project as beneficiaries and responsible for the implementation of key deliverables.
For more info, please visit https://www.sinfonia-appraisal.eu